Probiodrug AG
Records under this name other than the patents Probiodrug AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,889,709 | Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,676,843 | Uses of antibodies directed against amyloid-β Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,058,405 | Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,173,885 | Inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,650,362 | Inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,486,940 | Inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,269,019 | Inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,420,828 | Inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,541,596 | Inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,962,860 | Novel Inhibitors of Glutaminyl Cyclase Formerly held In force · Medium confidence | In force | Medium confidence |